Doximity: I Called The Pop Over A Month Ago, But Now Is The Time To Wait (Rating Downgrade)

Doximity delivered strong fiscal Q1 2027 results, validating my prior bullish stance on valuation and AI-driven growth. The stock surged over 30% intraday, reflecting the market's recognition of DOCS's evolving business model and earnings strength. DOCS is transforming physician searches into a new commercial marketplace, leveraging AI Search to monetize real-time physician intent. AI integration is positioning DOCS to capture value at the critical point of physician decision-making, enhancing its pharmaceutical advertising business. PM Images/DigitalVision via Getty Images I last wrote about Doximity ( DOCS ) on June 30, 2026, and I was excited to tell my readers why I felt that Wall Street was missing the valuation and AI stories for This article was written by Ryan Canady 592 Followers Follow Investing wisely does not have to be rocket science. It is about discipline and running the numbers. You don't have to be like a grandmaster chess player playing the game twenty moves ahead of your opponent, you just need to understand how the pieces work.